Dynocardia, Inc.
Newton, MA Doing business as Dynocardia Inc.
- UEI
- HMN7FWLXJ1H4
- CAGE
- 87W08
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1188 Centre St #2, Newton Centre, MA 02459, USA
- Website
- dynocardia.care
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II: development of motion artifact correction systems for vitrack: an accurate, continuous, and… | National Science Foundation | $999,553 | |
| Design verification and validation of vitrack - an accurate, continuous, non-invasive blood pressure monitor - project… | National Heart Lung and Blood Institute | $499,881 | |
| Vitrack: wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy… | National Heart Lung and Blood Institute | $7,189,212 | |
| Sbir phase i: motion artifact management for accurate and continuous non-invasive blood pressure monitoring -the broader… | Division of Industrial Innovation | $256,000 | |
| Development of a novel cuff-less wrist wearable continuous blood pressure monitor - project summary there is an unmet… | National Heart Lung and Blood Institute | $5,080,780 |
About Dynocardia, Inc.
Dynocardia, Inc. is a for-profit corporate entity registered in SAM.gov, with its primary address located in Newton Centre, Massachusetts. The company focuses on developing advanced medical technology, specifically innovative wearable medical devices for continuous and non-invasive blood pressure monitoring. Their flagship product, Vitrack, is a wrist-wearable device that utilizes proprietary optomechanical sensor technology and computer vision algorithms to provide accurate, beat-to-beat blood pressure measurements across various clinical settings.
Through multiple federal grant awards, primarily from the National Science Foundation (NSF) and the National Heart, Lung, and Blood Institute (NHLBI), Dynocardia has been developing and refining its Vitrack device through Small Business Innovation Research (SBIR) Phase I and Phase II grants. These awards, totaling approximately $1.7 million, have supported the company's efforts to address critical challenges in blood pressure monitoring, such as motion artifact correction, continuous measurement in hospital intensive care and operating room settings, and specialized applications like monitoring hypertensive diseases during pregnancy. The grants have enabled Dynocardia to develop advanced computer vision algorithms, create synthetic training data, integrate artificial intelligence for motion correction, and conduct clinical validations of their technology. The ultimate goal of these projects is to create a production-ready device that can provide accurate, continuous blood pressure monitoring, potentially improving patient outcomes in hospitals, remote patient monitoring, and consumer wellness markets.
Quick answers
What is Dynocardia, Inc.'s UEI?
Dynocardia, Inc.'s Unique Entity ID (UEI) in SAM.gov is HMN7FWLXJ1H4.
What is Dynocardia, Inc.'s CAGE code?
Dynocardia, Inc.'s CAGE code is 87W08.
What is Dynocardia, Inc.'s primary NAICS code?
Dynocardia, Inc.'s primary NAICS code is 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing).
Where is Dynocardia, Inc. located?
Dynocardia, Inc.'s physical address in SAM.gov is 1188 Centre St #2, Newton Centre, MA 02459, USA.
Is Dynocardia, Inc. registered in SAM.gov?
Yes. Dynocardia, Inc.'s SAM.gov registration is active through February 5, 2027.
What is Dynocardia, Inc.'s most recent federal award?
Dynocardia, Inc.'s most recent federal grant award is Sbir phase II: development of motion artifact correction systems for vitrack: an accurate, continuous, and… (2423296), from National Science Foundation, on September 15, 2024.
On GovTribe
See Dynocardia, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors